Cagrilintide

Cagrilintide is an investigational peptide-based drug designed to aid in weight management. It is a synthetic analog of the naturally occurring hormone amylin, which helps regulate appetite, glucose metabolism, and energy balance. Cagrilintide works by reducing food intake and promoting satiety, potentially leading to weight loss. It is being studied in combination with other medications, such as GLP-1 agonists, for enhanced efficacy in treating obesity and related metabolic conditions.